Murine model for human carcinoma
US5986170A · kind A · utility
46Cited by
2References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 13, 1995 |
| Grant date | Nov 16, 1999 |
| Priority date | — |
| Expiry date | Nov 13, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A murine model for human ovarian and prostate cancer is provided. The model comprises an immunodeficient mouse containing human primary ovarian or prostate carcinoma tissue implanted within the gonadal fat pad. Methods of using the murine model, for example, to grow tumors and to screen treatments for ovarian and/or prostate cancer are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.